相关实验视频

Updated: Jul 8, 2025

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

肺热带AAV囊体的相互突变导致转导特性得到改善

Ashley L Cooney^1,2,3, Christian M Brommel^1,2,3, Soumba Traore^1,2,3

¹University of Iowa, Stead Family Department of Pediatrics, Iowa City, IA, United States.

Frontiers in genome editing

|December 11, 2023

概括

腺关联病毒 (AAV) 囊被设计为改善囊性纤维化 (CF) 的基因疗法. 修改后的AAV囊体显示了呼吸道上皮和基底细胞的增强转导,为有效的CFTR基因修复铺平了道路.

科学领域:

基因治疗基因治疗
分子生物学分子生物学
病毒学病毒学

背景情况:

基于腺相关病毒 (AAV) 的载体对于囊性纤维化 (CF) 基因治疗至关重要.
像AAV2.5T和AAV6.2这样的进化AAV囊体显示出改善的气道上皮细胞转导.
对于有效的CF基因治疗策略来说,了解这些体的特定细胞热带性至关重要.

研究的目的:

为了研究人类呼吸道上皮细胞中工程AAV体的细胞热带性.
通过向基底干细胞,评估修改后的AAV囊在CF中长寿基因治疗的潜力.
开发基于AAV的腺基编辑器,用于纠正CFTR R553X突变.

主要方法:

使用了分化良好的人类呼吸道上皮细胞 (HAE) 和人类呼吸道基底细胞的初级培养.
评估了AAV2.5T和AAV6.2囊对表面上皮细胞和基底细胞的热带性.
AAV6.2FF体和相互突变的基因被设计和测试以改善转导.
与AAV一起使用分离-intein方法来提供用于CFTR修复的腺基编辑器 (ABE).

主要成果:

与AAV6.2.2相比,AAV2.5T显示了表面上皮细胞的优异转导,而AAV6.2.
在AAV2.5T.上,AAV6.2显示了气道基底细胞的增强转导.
具有特定突变的工程AAV体表现出改善的气道表面和原始细胞的转导.
通过AAV成功输送腺基编辑器 (ABE) 来修复CFTR R553X突变.

结论:

对AAV囊突变的合理设计和工程可以显著提高气道上皮和基底细胞的转导效率.
用优化的AAV载体准表面上皮细胞和基底前体细胞是长期CF基因治疗的有希望的策略.
以AAV为媒介的基编辑为纠正特定CFTR突变提供了潜在的治疗方法,旨在改善CF患者的肺功能.

关键词:

腺相关病毒囊体呼吸道上皮质上发生了什么?基础编辑基础编辑囊性纤维化症是什么基因治疗的基因疗法

更多相关视频

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

相关概念视频

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...